{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:54:13Z","timestamp":1790679253365,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,4]],"date-time":"2016-01-04T00:00:00Z","timestamp":1451865600000},"content-version":"vor","delay-in-days":552,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1038\/ki.2013.520","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T08:46:42Z","timestamp":1389170802000},"page":"58-66","source":"Crossref","is-referenced-by-count":89,"title":["Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry disease"],"prefix":"10.1016","volume":"86","author":[{"given":"Liming","family":"Shu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Vivekanandan-Giri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subramaniam","family":"Pennathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouwien E.","family":"Smid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes M.F.G.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla E.M.","family":"Hollak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Shayman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2013.520_bb0010","first-page":"CD006663","article-title":"Enzyme replacement therapy for Anderson-Fabry disease","volume":"2","author":"El Dib","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1038\/ki.2013.520_bb0015","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/01.ASN.0000043901.45141.D4","article-title":"Fabry disease in mice is associated with age-dependent susceptibility to vascular thrombosis","volume":"14","author":"Eitzman","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.520_bb0020","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/01.CIR.0000154550.15963.80","article-title":"Alpha-galactosidase A deficiency accelerates atherosclerosis in mice with apolipoprotein E deficiency","volume":"111","author":"Bodary","year":"2005","journal-title":"Circulation"},{"key":"10.1038\/ki.2013.520_bb0025","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1440-1681.2008.04984.x","article-title":"Vascular dysfunction in the alpha-galactosidase A-knockout mouse is an endothelial cell-, plasma membrane-based defect","volume":"35","author":"Park","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1038\/ki.2013.520_bb0030","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1681\/ASN.2008111190","article-title":"Decreased nitric oxide bioavailability in a mouse model of Fabry disease","volume":"20","author":"Shu","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.520_bb0035","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.physiol.64.081501.155952","article-title":"Regulation of endothelial nitric oxide synthase: location, location, location","volume":"64","author":"Shaul","year":"2002","journal-title":"Annu Rev Physiol"},{"key":"10.1038\/ki.2013.520_bb0040","doi-asserted-by":"crossref","first-page":"E481","DOI":"10.1152\/ajpendo.00540.2011","article-title":"Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities","volume":"302","author":"Kietadisorn","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1038\/ki.2013.520_bb0045","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/BF02623694","article-title":"Endothelium specific Weibel-Palade bodies in a continuous human cell line, EA.hy926","volume":"26","author":"Edgell","year":"1990","journal-title":"In Vitro Cell Dev Biol"},{"key":"10.1038\/ki.2013.520_bb0050","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1073\/pnas.80.12.3734","article-title":"Permanent cell line expressing human factor VIII-related antigen established by hybridization","volume":"80","author":"Edgell","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2013.520_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/abbi.1998.0755","article-title":"Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species","volume":"356","author":"Ischiropoulos","year":"1998","journal-title":"Arch Biochem Biophys"},{"key":"10.1038\/ki.2013.520_bb0060","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.ph.28.030166.002251","article-title":"Functions of lysosomes","volume":"28","author":"De Duve","year":"1966","journal-title":"Annu Rev Physiol"},{"key":"10.1038\/ki.2013.520_bb0065","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1126\/science.167.3922.1268","article-title":"Fabry's disease: alpha-galactosidase deficiency","volume":"167","author":"Kint","year":"1970","journal-title":"Science"},{"key":"10.1038\/ki.2013.520_bb0070","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/jid.1965.22","article-title":"Angiokeratoma Corporis Diffusum (Fabry). Histochemical and electron microscopic studies of the skin","volume":"44","author":"Hashimoto","year":"1965","journal-title":"J Invest Dermatol"},{"key":"10.1038\/ki.2013.520_bb0075","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1016\/S0021-9258(18)51888-3","article-title":"Fabry\u2019s Disease: Classification as a Sphingolipidosis and Partial Characterization of a Novel Glycolipid","volume":"238","author":"Sweeley","year":"1963","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2013.520_bb0080","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","article-title":"Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency","volume":"276","author":"Brady","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2013.520_bb0085","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1086\/422366","article-title":"Long-term safety and efficacy of enzyme replacement therapy for Fabry disease","volume":"75","author":"Wilcox","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1038\/ki.2013.520_bb0090","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1681\/ASN.2006080816","article-title":"Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease","volume":"18","author":"Germain","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.520_bb0095","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ymgme.2009.10.004","article-title":"Vasculopathy in patients with Fabry disease: current controversies and research directions","volume":"99","author":"Rombach","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1038\/ki.2013.520_bb0100","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1681\/ASN.2005040383","article-title":"An in vitro model of Fabry disease","volume":"16","author":"Shu","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.520_bb0105","doi-asserted-by":"crossref","first-page":"20960","DOI":"10.1074\/jbc.M702436200","article-title":"Caveolin-associated accumulation of globotriaosylceramide in the vascular endothelium of alpha-galactosidase A null mice","volume":"282","author":"Shu","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2013.520_bb0110","first-page":"1","article-title":"Glycosphingolipid mediated caveolin-1 oligomerization","volume":"S2","author":"Shu","year":"2012","journal-title":"J Glycomics Lipidomics"},{"key":"10.1038\/ki.2013.520_bb0115","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s10545-006-0340-x","article-title":"Structural and functional changes in peripheral vasculature of Fabry patients","volume":"29","author":"Kalliokoski","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1038\/ki.2013.520_bb0120","first-page":"295","article-title":"Non invasive evaluation of endothelial function in patients with Anderson-Fabry disease","volume":"24","author":"Puccio","year":"2005","journal-title":"Int Angiol"},{"key":"10.1038\/ki.2013.520_bb0125","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1007\/s00415-003-1133-x","article-title":"Postischemic cutaneous hyperperfusion in the presence of forearm hypoperfusion suggests sympathetic vasomotor dysfunction in Fabry disease","volume":"250","author":"Stemper","year":"2003","journal-title":"J Neurol"},{"key":"10.1038\/ki.2013.520_bb0130","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/0002-8703(83)90241-7","article-title":"Peripheral hemodynamics in patients with Fabry's disease","volume":"105","author":"Seino","year":"1983","journal-title":"Am Heart J"},{"key":"10.1038\/ki.2013.520_bb0135","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10545-005-0563-2","article-title":"Impaired myocardial perfusion reserve but preserved peripheral endothelial function in patients with Fabry disease","volume":"28","author":"Kalliokoski","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"10.1038\/ki.2013.520_bb0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1476-7120-3-11","article-title":"Reduced coronary flow reserve in Anderson-Fabry disease measured by transthoracic Doppler echocardiography","volume":"3","author":"Dimitrow","year":"2005","journal-title":"Cardiovasc Ultrasound"},{"key":"10.1038\/ki.2013.520_bb0145","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1161\/01.STR.32.7.1559","article-title":"Enhanced endothelium-dependent vasodilation in Fabry disease","volume":"32","author":"Altarescu","year":"2001","journal-title":"Stroke"},{"key":"10.1038\/ki.2013.520_bb0150","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s00415-004-0364-9","article-title":"Reduced cerebral blood flow velocity and impaired cerebral autoregulation in patients with Fabry disease","volume":"251","author":"Hilz","year":"2004","journal-title":"J Neurol"},{"key":"10.1038\/ki.2013.520_bb0155","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/hs0202.102601","article-title":"Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement","volume":"33","author":"Moore","year":"2002","journal-title":"Stroke"},{"key":"10.1038\/ki.2013.520_bb0160","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2008.06.016","article-title":"Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells","volume":"95","author":"Shen","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1038\/ki.2013.520_bb0165","doi-asserted-by":"crossref","first-page":"42977","DOI":"10.1074\/jbc.M406762200","article-title":"Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species","volume":"279","author":"Pennathur","year":"2004","journal-title":"The J Biol Chem"},{"key":"10.1038\/ki.2013.520_bb0170","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1001\/jama.289.13.1675","article-title":"Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy","volume":"289","author":"Shishehbor","year":"2003","journal-title":"JAMA"},{"key":"10.1038\/ki.2013.520_bb0175","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0891-5849(02)00792-X","article-title":"Oxidized amino acids: culprits in human atherosclerosis and indicators of oxidative stress","volume":"32","author":"Heinecke","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"10.1038\/ki.2013.520_bb0180","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/B978-0-12-385928-0.00005-5","article-title":"Quantitative analysis of amino Acid oxidation markers by tandem mass spectrometry","volume":"491","author":"Vivekanandan-Giri","year":"2011","journal-title":"Methods Enzymol"},{"key":"10.1038\/ki.2013.520_bb0185","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0009-8981(81)90384-3","article-title":"Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease","volume":"112","author":"Mayes","year":"1981","journal-title":"Clin Chim Acta"},{"key":"10.1038\/ki.2013.520_bb0190","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","author":"Aerts","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2013.520_bb0195","series-title":"J Med Genet","article-title":"A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance","author":"van der Tol","year":"2013"},{"key":"10.1038\/ki.2013.520_bb0200","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1373\/clinchem.2012.192138","article-title":"Quantification of globotriaosylsphingosine in plasma and urine of fabry patients by stable isotope ultraperformance liquid chromatography-tandem mass spectrometry","volume":"59","author":"Gold","year":"2013","journal-title":"Clin Chem"},{"key":"10.1038\/ki.2013.520_bb0205","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/HYPERTENSIONAHA.112.195685","article-title":"Vascular aspects of Fabry disease in relation to clinical manifestations and elevations in plasma globotriaosylsphingosine","volume":"60","author":"Rombach","year":"2012","journal-title":"Hypertension"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815302544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815302544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T18:42:03Z","timestamp":1647888123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815302544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0085253815302544"],"URL":"https:\/\/doi.org\/10.1038\/ki.2013.520","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}